Precision Biosciences Income Statement (2018-2026) | DTIL

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
68.81M24.04M6.34M3.32M3.82M7.36M10.60M8.78M19.79M13.12M7.04M17.58M49.90M0.58M0.64M0.03M0.02M0.01M34.20M10.84M
Operating items
Research & Development (Quarter)
37.23M25.94M26.47M19.97M22.94M11.76M12.68M11.05M13.09M15.85M13.39M13.34M17.23M13.08M15.91M13.59M12.77M13.35M14.46M13.11M
Selling, General & Administrative (Quarter)
9.94M9.64M10.59M10.68M10.44M10.28M10.02M11.09M9.83M9.63M8.54M8.43M8.53M8.77M9.58M8.55M9.13M7.33M7.23M6.80M
Other Operating Expenses (Quarter)
-0.01M-0.05M0.05M-0.02M-0.01M0.07M-0.00M-0.52M-0.07M-0.19M-0.18M-0.01M-0.03M0.00M-0.39M0.00M
Operating Expenses (Quarter)
47.17M35.58M37.06M30.65M33.37M22.04M22.71M22.13M22.92M25.48M21.93M21.77M25.75M21.85M25.48M22.14M21.89M20.68M21.70M19.91M
Operating Income (Quarter)
21.63M-11.54M-30.72M-27.34M-29.55M-14.68M-12.11M-13.35M-3.13M-12.36M-14.89M-4.19M24.15M-21.27M-24.85M-22.11M-21.88M-20.67M12.51M-9.07M
EBIT (Quarter)
21.63M-11.54M-30.72M-27.34M-29.55M-14.68M-12.11M-13.35M-3.13M-12.36M-14.89M-4.19M24.15M-21.27M-24.85M-22.11M-21.88M-20.67M12.51M-9.07M
Non-operating items
Non Operating Investment Income (Quarter)
0.27M-0.51M-0.77M0.31M1.60M-0.35M0.69M0.57M-0.66M0.05M-2.46M-0.00M-0.25M-2.95M
Interest & Investment Income (Quarter)
0.05M0.04M0.06M0.17M0.19M1.17M1.94M2.04M1.95M1.87M1.83M1.66M1.84M1.76M1.49M1.32M1.12M1.03M0.77M1.00M
Other Non Operating Income (Quarter)
0.02M0.26M5.64M-0.83M-1.48M-1.01M-7.32M-0.60M0.10M0.25M1.46M12.78M8.60M4.85M7.10M1.55M-1.64M-1.10M6.77M-9.37M
Net income details
EBT (Quarter)
19.55M-22.12M-30.76M-34.23M-35.86M-14.03M-12.01M-11.88M-7.58M-10.79M-13.80M-3.10M15.57M-29.46M-23.85M-21.27M-22.17M-27.64M12.39M-8.57M
Profit After Tax (Quarter)
21.66M-11.28M-22.29M-28.17M-31.04M-15.69M-58.16M-25.06M-11.89M-12.11M-13.43M8.59M32.75M-16.43M-17.75M-20.57M-23.52M-21.77M19.25M-18.44M
Income from Continuing Operations (Quarter)
19.55M-22.12M-30.76M-34.23M-35.86M-14.03M-12.01M-11.88M-7.58M-10.79M-13.80M-3.10M15.57M-29.46M-23.85M-21.27M-22.17M-27.64M12.39M-8.57M
Consolidated Net Income (Quarter)
19.55M-22.12M-30.76M-34.23M-35.86M-8.26M-9.06M-11.11M-8.86M4.03M-2.85M-3.10M15.57M-29.46M-23.85M-21.27M-22.17M-27.64M12.39M-8.57M
Income towards Parent Company (Quarter)
19.55M-22.12M-30.76M-34.23M-35.86M-8.26M-9.06M-11.11M-8.86M4.03M-2.85M-3.10M15.57M-29.46M-23.85M-21.27M-22.17M-27.64M12.39M-8.57M
Net Income towards Common Stockholders (Quarter)
19.55M-22.12M-30.76M-34.23M-35.86M-8.26M-9.06M-11.11M-8.86M4.03M-2.85M-3.10M15.57M-29.46M-23.85M-21.27M-22.17M-27.64M12.39M-8.57M
Additional items
EPS (Basic) (Quarter)
10.16-11.13-15.72-16.83-15.83-2.23-3.09-2.99-2.331.05-0.74-0.612.23-4.04-3.49-2.29-2.01-2.340.97-0.35
EPS (Diluted) (Quarter)
9.80-11.13-15.72-16.83-15.83-2.23-3.09-2.99-2.331.05-0.74-0.612.22-4.04-3.46-2.29-2.01-2.340.97-0.35
Shares Outstanding (Quarter)
1.92M1.99M1.96M2.03M2.26M3.69M2.93M3.71M3.80M3.84M3.84M5.06M6.97M7.29M6.83M9.29M11.05M11.82M12.83M24.63M
Shares Outstanding (Diluted) (Quarter)
1.99M1.99M1.96M2.03M2.26M3.69M2.93M3.71M3.80M3.84M3.84M5.06M7.01M7.29M6.88M9.29M11.05M11.82M12.83M24.63M
Shares Outstanding (Entity) (Quarter)
2.00M2.03M2.06M2.09M2.26M3.72M2.93M3.77M3.86M3.88M4.19M5.06M7.15M7.51M6.83M10.58M11.66M12.11M12.83M
EBITDA (Quarter)
21.63M-11.54M-30.72M-27.34M-29.55M-14.68M-12.11M-13.35M-3.13M-12.36M-14.89M-4.19M24.15M-21.27M-24.85M-22.11M-21.88M-20.67M12.51M-9.07M
Interest Expenses (Quarter)
2.13M10.62M0.10M7.07M6.50M0.53M1.84M0.57M6.40M0.30M0.74M0.57M10.42M9.95M0.50M0.48M1.41M8.01M0.89M0.50M